Low muscle mass in COVID-19 critically-ill patients: Prognostic significance and surrogate markers for assessment
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 41 (12) , 2910-2917
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the “modified NUTRIC” nutritional risk assessment toolClinical Nutrition, 2016
- Sarcopenia and cachexia in the era of obesity: clinical and nutritional impactProceedings of the Nutrition Society, 2016
- Effect of Intravenous Infusion Solutions on Bioelectrical Impedance SpectroscopyJournal of Parenteral and Enteral Nutrition, 2015
- Diagnostic criteria for malnutrition – An ESPEN Consensus StatementClinical Nutrition, 2015
- Measurement of skeletal muscle radiation attenuation and basis of its biological variationActa Physiologica, 2014
- Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patientsCritical Care, 2014
- Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patientsCritical Care, 2013
- The emerging role of computerized tomography in assessing cancer cachexiaCurrent Opinion in Supportive & Palliative Care, 2009
- Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional imageJournal of Applied Physiology, 2004
- Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 yInternational Journal of Obesity, 2002